Home > News > Genetic sequencing and blood analysis could transform medicine
April 29th, 2005
Genetic sequencing and blood analysis could transform medicine
Abstract:
In as little as 10 years, Leroy Hood, a leading expert on the human genome, predicts that everyone in the United States could have his or her DNA mapped, leading to an array of business opportunities for biotechnology and data companies. Speaking to the Washington Biotechnology and Biomedical Association's annual investment conference in Seattle on Monday, Hood talked about a revolutionary shift of using detailed blood analysis and a person's genetic sequencing to move medical diagnosis from the reactive to the predictive.
Source:
smalltimes
Related News Press |
Possible Futures
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||